{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:32:35Z","timestamp":1790519555113,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFE0202200"],"award-info":[{"award-number":["2020YFE0202200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82090051"],"award-info":[{"award-number":["82090051"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hepatocellular carcinoma (HCC) seriously threatens human health, mostly developed from liver fibrosis or cirrhosis. Since diethylnitrosamine (DEN) and carbon tetrachloride (CCl\n                    <jats:sub>4<\/jats:sub>\n                    )-induced HCC mouse model almost recapitulates the characteristic of HCC with fibrosis and inflammation, it is taken as an essential tool to investigate the pathogenesis of HCC. However, a comprehensive understanding of the protein expression profile of this model is little. In this study, we performed proteomic analysis of this model to elucidate its proteomic characteristics. Compared with normal liver tissues, 432 differentially expressed proteins (DEPs) were identified in tumor tissues, among which 365 were up-regulated and 67 were down-regulated. Through Gene Ontology (GO) analysis, Ingenuity Pathway Analysis (IPA), protein\u2013protein interaction networks (PPI) analysis and Gene-set enrichment analysis (GSEA) analysis of DEPs, we identified two distinguishing features of DEN and CCl\n                    <jats:sub>4<\/jats:sub>\n                    -induced HCC mouse model in protein expression, the upregulation of actin cytoskeleton and branched-chain amino acids metabolic reprogramming. In addition, matching DEPs from the mouse model to homologous proteins in the human HCC cohort revealed that the DEN and CCl\n                    <jats:sub>4<\/jats:sub>\n                    -induced HCC mouse model was relatively similar to the subtype of HCC with poor prognosis. Finally, combining clinical information from the HCC cohort, we screened seven proteins with prognostic significance, SMAD2, PTPN1, PCNA, MTHFD1L, MBOAT7, FABP5, and AGRN. Overall, we provided proteomic data of the DEN and CCl\n                    <jats:sub>4<\/jats:sub>\n                    -induced HCC mouse model and highlighted the important proteins and pathways in it, contributing to the rational application of this model in HCC research.\n                  <\/jats:p>","DOI":"10.1038\/s41598-024-58587-6","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T05:02:06Z","timestamp":1712293326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Proteomic analysis of DEN and CCl4-induced hepatocellular carcinoma mouse model"],"prefix":"10.1038","volume":"14","author":[{"given":"Qian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangliang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiran","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,5]]},"reference":[{"key":"58587_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"58587_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Primers 7, 6. https:\/\/doi.org\/10.1038\/s41572-020-00240-3 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"58587_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel, A., Meyer, T., Sapisochin, G., Salem, R. & Saborowski, A. Hepatocellular carcinoma. Lancet 400, 1345\u20131362. https:\/\/doi.org\/10.1016\/S0140-6736(22)01200-4 (2022).","journal-title":"Lancet"},{"key":"58587_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2011.196","volume":"9","author":"Y Li","year":"2011","unstructured":"Li, Y., Tang, Z. Y. & Hou, J. X. Hepatocellular carcinoma: Insight from animal models. Nat. Rev. Gastroenterol. Hepatol. 9, 32\u201343. https:\/\/doi.org\/10.1038\/nrgastro.2011.196 (2011).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"58587_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/0471141755.ph1430s66","volume":"66","author":"T Uehara","year":"2014","unstructured":"Uehara, T., Pogribny, I. P. & Rusyn, I. The DEN and CCl4 -induced mouse model of fibrosis and inflammation-associated hepatocellular carcinoma. Curr. Protoc. Pharmacol. 66, 11\u201310. https:\/\/doi.org\/10.1002\/0471141755.ph1430s66 (2014).","journal-title":"Curr. Protoc. Pharmacol."},{"key":"58587_CR6","doi-asserted-by":"publisher","first-page":"113042","DOI":"10.1016\/j.yexcr.2022.113042","volume":"412","author":"CY Gu","year":"2022","unstructured":"Gu, C. Y. & Lee, T. K. W. Preclinical mouse models of hepatocellular carcinoma: An overview and update. Exp. Cell Res. 412, 113042. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113042 (2022).","journal-title":"Exp. Cell Res."},{"key":"58587_CR7","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.jhep.2018.06.009","volume":"69","author":"C Frances","year":"2018","unstructured":"Frances, C. et al. Mutational landscape of a chemically-induced mouse model of liver cancer. J. Hepatol. 69, 840\u2013850. https:\/\/doi.org\/10.1016\/j.jhep.2018.06.009 (2018).","journal-title":"J. Hepatol."},{"key":"58587_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.etp.2014.03.003","volume":"66","author":"K Ding","year":"2014","unstructured":"Ding, K. et al. Establishment of a liver fibrosis model in cynomolgus monkeys. Exp. Toxicol. Pathol. 66, 257\u2013261. https:\/\/doi.org\/10.1016\/j.etp.2014.03.003 (2014).","journal-title":"Exp. Toxicol. Pathol."},{"key":"58587_CR9","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.bbadis.2018.08.009","volume":"1865","author":"EZ Hui","year":"2019","unstructured":"Hui, E. Z., James, M. H. & Gorrell, M. D. Animal models for hepatocellular carcinoma. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 993\u20131002. https:\/\/doi.org\/10.1016\/j.bbadis.2018.08.009 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"58587_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/10590500701569398","volume":"25","author":"MK Manibusan","year":"2007","unstructured":"Manibusan, M. K., Odin, M. & Eastmond, D. A. Postulated carbon tetrachloride mode of action: A review. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 25, 185\u2013209. https:\/\/doi.org\/10.1080\/10590500701569398 (2007).","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"key":"58587_CR11","first-page":"325","volume":"6","author":"BE Allen","year":"1946","unstructured":"Allen, B. E. & Miller, L. Liver necrosis and the induction of carbon tetrachloride hepatomas in strain A mice. J. Natl. Cancer Inst. 6, 325\u2013341 (1946).","journal-title":"J. Natl. Cancer Inst."},{"key":"58587_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/15287398709531051","volume":"22","author":"DJ Doolittle","year":"1987","unstructured":"Doolittle, D. J., Muller, G. & Scribner, H. E. Relationship between hepatotoxicity and induction of replicative DNA synthesis following single or multiple doses of carbon tetrachloride. J. Toxicol. Environ. Health 22, 63\u201378. https:\/\/doi.org\/10.1080\/15287398709531051 (1987).","journal-title":"J. Toxicol. Environ. Health"},{"key":"58587_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1365-2613.2009.00656.x","volume":"90","author":"F Heindryckx","year":"2009","unstructured":"Heindryckx, F., Colle, I. & Van Vlierberghe, H. Experimental mouse models for hepatocellular carcinoma research. Int. J. Exp. Pathol. 90, 367\u2013386. https:\/\/doi.org\/10.1111\/j.1365-2613.2009.00656.x (2009).","journal-title":"Int. J. Exp. Pathol."},{"key":"58587_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/toxsci\/kfs342","volume":"132","author":"T Uehara","year":"2013","unstructured":"Uehara, T. et al. Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis. Toxicol. Sci. 132, 53\u201363. https:\/\/doi.org\/10.1093\/toxsci\/kfs342 (2013).","journal-title":"Toxicol. Sci."},{"key":"58587_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41419-018-0267-9","volume":"9","author":"Q Wu","year":"2018","unstructured":"Wu, Q. et al. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K\/Akt pathway activation. Cell Death Dis. 9, 232. https:\/\/doi.org\/10.1038\/s41419-018-0267-9 (2018).","journal-title":"Cell Death Dis."},{"key":"58587_CR16","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1158\/1541-7786.MCR-18-0313","volume":"16","author":"SY Yim","year":"2018","unstructured":"Yim, S. Y. et al. Integrated genomic comparison of mouse models reveals their clinical resemblance to human liver cancer. Mol. Cancer Res. 16, 1713\u20131723. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0313 (2018).","journal-title":"Mol. Cancer Res."},{"key":"58587_CR17","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/ng1481","volume":"36","author":"JS Lee","year":"2004","unstructured":"Lee, J. S. et al. Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat. Genet. 36, 1306\u20131311. https:\/\/doi.org\/10.1038\/ng1481 (2004).","journal-title":"Nat. Genet."},{"key":"58587_CR18","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/2211-5463.12724","volume":"9","author":"J Sun","year":"2019","unstructured":"Sun, J. et al. Whole transcriptome analysis of chemically induced hepatocellular carcinoma using RNA-sequencing analysis. FEBS Open Bio 9, 1900\u20131908. https:\/\/doi.org\/10.1002\/2211-5463.12724 (2019).","journal-title":"FEBS Open Bio"},{"key":"58587_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1440-1843.2006.00957.x","volume":"12","author":"T Kikuchi","year":"2007","unstructured":"Kikuchi, T. & Carbone, D. P. Proteomics analysis in lung cancer: Challenges and opportunities. Respirology 12, 22\u201328. https:\/\/doi.org\/10.1111\/j.1440-1843.2006.00957.x (2007).","journal-title":"Respirology"},{"key":"58587_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wisniewski","year":"2009","unstructured":"Wisniewski, J. R., Zougman, A., Nagaraj, N. & Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 6, 359\u2013362. https:\/\/doi.org\/10.1038\/nmeth.1322 (2009).","journal-title":"Nat. Methods"},{"key":"58587_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12967-022-03282-1","volume":"20","author":"Y Fang","year":"2022","unstructured":"Fang, Y. et al. The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomics. J. Transl. Med. 20, 88. https:\/\/doi.org\/10.1186\/s12967-022-03282-1 (2022).","journal-title":"J. Transl. Med."},{"key":"58587_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-019-0987-8","volume":"567","author":"Y Jiang","year":"2019","unstructured":"Jiang, Y. et al. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma. Nature 567, 257\u2013261. https:\/\/doi.org\/10.1038\/s41586-019-0987-8 (2019).","journal-title":"Nature"},{"key":"58587_CR23","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367\u20131372. https:\/\/doi.org\/10.1038\/nbt.1511 (2008).","journal-title":"Nat. Biotechnol."},{"key":"58587_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/nar\/gku989","volume":"43","author":"C UniProt","year":"2015","unstructured":"UniProt, C. UniProt: A hub for protein information. Nucleic Acids Res. 43, 204\u2013212. https:\/\/doi.org\/10.1093\/nar\/gku989 (2015).","journal-title":"Nucleic Acids Res."},{"key":"58587_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25\u201329. https:\/\/doi.org\/10.1038\/75556 (2000).","journal-title":"Nat. Genet."},{"key":"58587_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-4939-2297-0_8","volume":"1267","author":"MC Jorge","year":"2023","unstructured":"Jorge, M. C. & Schwabe, R. F. Mouse models of liver cancer. Methods Mol. Biol. Clifton, N. J. 1267, 165\u2013183. https:\/\/doi.org\/10.1007\/978-1-4939-2297-0_8 (2023).","journal-title":"Methods Mol. Biol. Clifton, N. J."},{"key":"58587_CR27","doi-asserted-by":"publisher","first-page":"11734","DOI":"10.1038\/srep11734","volume":"5","author":"TL Pan","year":"2015","unstructured":"Pan, T. L. et al. Herbal formula, Scutellariae radix and Rhei rhizoma attenuate dimethylnitrosamine-induced liver fibrosis in a rat model. Sci. Rep. 5, 11734. https:\/\/doi.org\/10.1038\/srep11734 (2015).","journal-title":"Sci. Rep."},{"key":"58587_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41580-018-0067-1","volume":"20","author":"M Dogterom","year":"2019","unstructured":"Dogterom, M. & Koenderink, G. H. Actin-microtubule crosstalk in cell biology. Nat. Rev. Mol. Cell Biol. 20, 38\u201354. https:\/\/doi.org\/10.1038\/s41580-018-0067-1 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"58587_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/cells10071831","volume":"2021","author":"N Mosaddeghzadeh","year":"2021","unstructured":"Mosaddeghzadeh, N. & Ahmadian, M. R. The RHO family GTPases: Mechanisms of regulation and signaling. Cells 2021, 10. https:\/\/doi.org\/10.3390\/cells10071831 (2021).","journal-title":"Cells"},{"key":"58587_CR30","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1126\/science.285.5430.1028","volume":"285","author":"FG Giancotti","year":"1999","unstructured":"Giancotti, F. G. & Ruoslahti, E. Integrin signaling. Science 285, 1028\u20131033. https:\/\/doi.org\/10.1126\/science.285.5430.1028 (1999).","journal-title":"Science"},{"key":"58587_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcp.21110","volume":"213","author":"A Woods","year":"2007","unstructured":"Woods, A., Wang, G. & Beier, F. Regulation of chondrocyte differentiation by the actin cytoskeleton and adhesive interactions. J. Cell. Physiol. 213, 1\u20138. https:\/\/doi.org\/10.1002\/jcp.21110 (2007).","journal-title":"J. Cell. Physiol."},{"key":"58587_CR32","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1006\/bbrc.1998.8253","volume":"245","author":"T Sasaki","year":"1998","unstructured":"Sasaki, T. & Takai, Y. The Rho small G protein family-rho GDI system as a temporal and spatial determinant for cytoskeletal control. Biochem. Biophys. Res. Commun. 245, 641\u2013645 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"58587_CR33","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6 (2019).","journal-title":"Nat. Commun."},{"key":"58587_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-4-2","volume":"2003","author":"GD Bader","year":"2003","unstructured":"Bader, G. D. & Hogue, C. W. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform. 2003, 4. https:\/\/doi.org\/10.1186\/1471-2105-4-2 (2003).","journal-title":"BMC Bioinform."},{"key":"58587_CR35","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: New perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353\u2013D361. https:\/\/doi.org\/10.1093\/nar\/gkw1092 (2017).","journal-title":"Nucleic Acids Res."},{"key":"58587_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-physiol-020518-114455","volume":"81","author":"M Neinast","year":"2019","unstructured":"Neinast, M., Murashige, D. & Arany, Z. Branched chain amino acids. Annu. Rev. Physiol. 81, 139\u2013164. https:\/\/doi.org\/10.1146\/annurev-physiol-020518-114455 (2019).","journal-title":"Annu. Rev. Physiol."},{"key":"58587_CR37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1055\/s-0039-3399502","volume":"40","author":"N Kang","year":"2020","unstructured":"Kang, N. Mechanotransduction in liver diseases. Semin. Liver Dis. 40, 84\u201390. https:\/\/doi.org\/10.1055\/s-0039-3399502 (2020).","journal-title":"Semin. Liver Dis."},{"key":"58587_CR38","doi-asserted-by":"publisher","first-page":"e77166","DOI":"10.1371\/journal.pone.0077166","volume":"8","author":"DC Rockey","year":"2013","unstructured":"Rockey, D. C., Weymouth, N. & Shi, Z. Smooth muscle alpha actin (Acta 2) and myofibroblast function during hepatic wound healing. PLoS One 8, e77166. https:\/\/doi.org\/10.1371\/journal.pone.0077166 (2013).","journal-title":"PLoS One"},{"key":"58587_CR39","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.32604\/biocell.2022.020171","volume":"46","author":"N Hijazi","year":"2022","unstructured":"Hijazi, N., Rockey, D. C. & Shi, Z. The cellular microenvironment and cytoskeletal actin dynamics in liver fibrogenesis. Biocell 46, 2003. https:\/\/doi.org\/10.32604\/biocell.2022.020171 (2022).","journal-title":"Biocell"},{"key":"58587_CR40","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/labinvest.2017.96","volume":"97","author":"Z Shi","year":"2017","unstructured":"Shi, Z. & Rockey, D. C. Upregulation of the actin cytoskeleton via myocardin leads to increased expression of type 1 collagen. Lab. Invest. 97, 1412\u20131426. https:\/\/doi.org\/10.1038\/labinvest.2017.96 (2017).","journal-title":"Lab. Invest."},{"key":"58587_CR41","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.1175862","volume":"326","author":"TD Pollard","year":"2009","unstructured":"Pollard, T. D. & Cooper, J. A. Actin, a central player in cell shape and movement. Science 326, 1208\u20131212. https:\/\/doi.org\/10.1126\/science.1175862 (2009).","journal-title":"Science"},{"key":"58587_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1101\/cshperspect.a018267","volume":"2018","author":"T Svitkina","year":"2018","unstructured":"Svitkina, T. The actin cytoskeleton and actin-based motility. Cold Spring Harb. Perspect. Biol. 2018, 10. https:\/\/doi.org\/10.1101\/cshperspect.a018267 (2018).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"58587_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/cells9102245","volume":"2020","author":"M Izdebska","year":"2020","unstructured":"Izdebska, M., Zieli\u0144ska, W., Ha\u0142as-Wi\u015bniewska, M. & Grzanka, A. Involvement of actin and actin-binding proteins in carcinogenesis. Cells 2020, 9. https:\/\/doi.org\/10.3390\/cells9102245 (2020).","journal-title":"Cells"},{"key":"58587_CR44","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/bs.ircmb.2020.05.006","volume":"356","author":"G Biber","year":"2020","unstructured":"Biber, G., Ben-Shmuel, A., Sabag, B. & Barda-Saad, M. Actin regulators in cancer progression and metastases: From structure and function to cytoskeletal dynamics. Int. Rev. Cell Mol. Biol. 356, 131\u2013196. https:\/\/doi.org\/10.1016\/bs.ircmb.2020.05.006 (2020).","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"58587_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/bs.ircmb.2020.05.002","volume":"355","author":"M Tafazzoli-Shadpour","year":"2020","unstructured":"Tafazzoli-Shadpour, M., Mohammadi, E. & Torkashvand, E. Mechanics of actin filaments in cancer onset and progress. Int. Rev. Cell Mol. Biol. 355, 205\u2013243. https:\/\/doi.org\/10.1016\/bs.ircmb.2020.05.002 (2020).","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"417\u2013429","key":"58587_CR46","doi-asserted-by":"publisher","first-page":"e414","DOI":"10.1016\/j.cmet.2018.10.013","volume":"29","author":"MD Neinast","year":"2019","unstructured":"Neinast, M. D. et al. Quantitative analysis of the whole-body metabolic fate of branched-chain amino acids. Cell Metab. 29(417\u2013429), e414. https:\/\/doi.org\/10.1016\/j.cmet.2018.10.013 (2019).","journal-title":"Cell Metab."},{"issue":"1151\u20131165","key":"58587_CR47","doi-asserted-by":"publisher","first-page":"e1156","DOI":"10.1016\/j.cmet.2018.12.020","volume":"29","author":"RE Ericksen","year":"2019","unstructured":"Ericksen, R. E. et al. Loss of BCAA catabolism during carcinogenesis enhances mTORC1 activity and promotes tumor development and progression. Cell Metab. 29(1151\u20131165), e1156. https:\/\/doi.org\/10.1016\/j.cmet.2018.12.020 (2019).","journal-title":"Cell Metab."},{"key":"58587_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111691","author":"D Yang","year":"2022","unstructured":"Yang, D. et al. Branched-chain amino acid catabolism breaks glutamine addiction to sustain hepatocellular carcinoma progression. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2022.111691 (2022).","journal-title":"Cell Rep."},{"key":"58587_CR49","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1074\/mcp.M116.060145","volume":"15","author":"C Ding","year":"2016","unstructured":"Ding, C. et al. A cell-type-resolved liver proteome. Mol. Cell Proteom. 15, 3190\u20133202. https:\/\/doi.org\/10.1074\/mcp.M116.060145 (2016).","journal-title":"Mol. Cell Proteom."},{"key":"58587_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jcb.21255","volume":"101","author":"KA Brown","year":"2007","unstructured":"Brown, K. A., Pietenpol, J. A. & Moses, H. L. A tale of two proteins: Differential roles and regulation of Smad2 and Smad3 in TGF-\u03b2 signaling. J. Cell. Biochem. 101, 9\u201333. https:\/\/doi.org\/10.1002\/jcb.21255 (2007).","journal-title":"J. Cell. Biochem."},{"key":"58587_CR51","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00535-013-0910-2","volume":"49","author":"K Matsuzaki","year":"2013","unstructured":"Matsuzaki, K., Seki, T. & Okazaki, K. TGF-\u03b2 signal shifting between tumor suppression and fibro-carcinogenesis in human chronic liver diseases. J. Gastroenterol. 49, 971\u2013981. https:\/\/doi.org\/10.1007\/s00535-013-0910-2 (2013).","journal-title":"J. Gastroenterol."},{"key":"58587_CR52","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.bbapap.2009.09.018","volume":"1804","author":"L Lessard","year":"2010","unstructured":"Lessard, L., Stuible, M. & Tremblay, M. L. The two faces of PTP1B in cancer. Biochim. Biophys. Acta 1804, 613\u2013619. https:\/\/doi.org\/10.1016\/j.bbapap.2009.09.018 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"58587_CR53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3892\/mmr.2022.12638","volume":"2022","author":"F Yuan","year":"2022","unstructured":"Yuan, F., Gao, Q., Tang, H., Shi, J. & Zhou, Y. Ophiopogonin-B targets PTP1B to inhibit the malignant progression of hepatocellular carcinoma by regulating the PI3K\/AKT and AMPK signaling pathways. Mol. Med. Rep. 2022, 25. https:\/\/doi.org\/10.3892\/mmr.2022.12638 (2022).","journal-title":"Mol. Med. Rep."},{"key":"58587_CR54","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/sj.onc.1200886","volume":"14","author":"Z Kelman","year":"1997","unstructured":"Kelman, Z. PCNA: Structure, functions and interactions. Oncogene 14, 629\u2013640. https:\/\/doi.org\/10.1038\/sj.onc.1200886 (1997).","journal-title":"Oncogene"},{"key":"58587_CR55","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1080\/09553000110069335","volume":"77","author":"T Paunesku","year":"2001","unstructured":"Paunesku, T. et al. Proliferating cell nuclear antigen (PCNA): Ringmaster of the genome. Int. J. Radiat. Biol. 77, 1007\u20131021. https:\/\/doi.org\/10.1080\/09553000110069335 (2001).","journal-title":"Int. J. Radiat. Biol."},{"key":"58587_CR56","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1042\/BST0370605","volume":"37","author":"I Stoimenov","year":"2009","unstructured":"Stoimenov, I. & Helleday, T. PCNA on the crossroad of cancer. Biochem. Soc. Trans. 37, 605\u2013613. https:\/\/doi.org\/10.1042\/BST0370605 (2009).","journal-title":"Biochem. Soc. Trans."},{"key":"58587_CR57","doi-asserted-by":"publisher","first-page":"7405","DOI":"10.1007\/s13277-015-4582-9","volume":"37","author":"S Ma","year":"2016","unstructured":"Ma, S., Yang, J., Li, J. & Song, J. The clinical utility of the proliferating cell nuclear antigen expression in patients with hepatocellular carcinoma. Tumour Biol. 37, 7405\u20137412. https:\/\/doi.org\/10.1007\/s13277-015-4582-9 (2016).","journal-title":"Tumour Biol."},{"key":"58587_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.nutr.012809.104810","volume":"30","author":"AS Tibbetts","year":"2010","unstructured":"Tibbetts, A. S. & Appling, D. R. Compartmentalization of Mammalian folate-mediated one-carbon metabolism. Annu. Rev. Nutr. 30, 57\u201381. https:\/\/doi.org\/10.1146\/annurev.nutr.012809.104810 (2010).","journal-title":"Annu. Rev. Nutr."},{"key":"58587_CR59","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1172\/JCI90253","volume":"127","author":"D Lee","year":"2017","unstructured":"Lee, D. et al. Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma. J. Clin. Invest. 127, 1856\u20131872. https:\/\/doi.org\/10.1172\/JCI90253 (2017).","journal-title":"J. Clin. Invest."},{"key":"58587_CR60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41598-017-04991-0","volume":"2017","author":"B Donati","year":"2017","unstructured":"Donati, B. et al. MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals. Sci. Rep. 2017, 7. https:\/\/doi.org\/10.1038\/s41598-017-04991-0 (2017).","journal-title":"Sci. Rep."},{"key":"58587_CR61","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1055\/s-0039-1681031","volume":"39","author":"N Fujiwara","year":"2019","unstructured":"Fujiwara, N. & Hoshida, Y. Hepatocellular carcinoma risk stratification by genetic profiling in patients with cirrhosis. Semin. Liver Dis. 39, 153\u2013162. https:\/\/doi.org\/10.1055\/s-0039-1681031 (2019).","journal-title":"Semin. Liver Dis."},{"key":"58587_CR62","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.jhep.2021.08.012","volume":"75","author":"GN Ioannou","year":"2021","unstructured":"Ioannou, G. N. Epidemiology and risk-stratification of NAFLD-associated HCC. J. Hepatol. 75, 1476\u20131484. https:\/\/doi.org\/10.1016\/j.jhep.2021.08.012 (2021).","journal-title":"J. Hepatol."},{"key":"58587_CR63","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.dld.2021.06.023","volume":"54","author":"L Valenti","year":"2022","unstructured":"Valenti, L., Pedica, F. & Colombo, M. Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease. Dig. Liver Dis. 54, 154\u2013163. https:\/\/doi.org\/10.1016\/j.dld.2021.06.023 (2022).","journal-title":"Dig. Liver Dis."},{"key":"58587_CR64","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/cam4.1020","volume":"6","author":"T Ohata","year":"2017","unstructured":"Ohata, T. et al. Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition. Cancer Med. 6, 1049\u20131061. https:\/\/doi.org\/10.1002\/cam4.1020 (2017).","journal-title":"Cancer Med."},{"key":"58587_CR65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s42003-020-01367-5","volume":"2020","author":"J Seo","year":"2020","unstructured":"Seo, J. et al. Fatty-acid-induced FABP5\/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells. Commun. Biol. 2020, 3. https:\/\/doi.org\/10.1038\/s42003-020-01367-5 (2020).","journal-title":"Commun. Biol."},{"key":"58587_CR66","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/jitc-2019-000501","volume":"2020","author":"F Liu","year":"2020","unstructured":"Liu, F. et al. Identification of FABP5 as an immunometabolic marker in human hepatocellular carcinoma. J. ImmunoTherapy Cancer 2020, 8. https:\/\/doi.org\/10.1136\/jitc-2019-000501 (2020).","journal-title":"J. ImmunoTherapy Cancer"},{"key":"58587_CR67","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1016\/j.csbj.2022.07.030","volume":"20","author":"L Tang","year":"2022","unstructured":"Tang, L. et al. Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma. Comput. Struct. Biotechnol. J. 20, 4402\u20134414. https:\/\/doi.org\/10.1016\/j.csbj.2022.07.030 (2022).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"58587_CR68","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1038\/s41417-022-00510-0","volume":"29","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Lipid-related FABP5 activation of tumor-associated monocytes fosters immune privilege via PD-L1 expression on Treg cells in hepatocellular carcinoma. Cancer Gene Ther. 29, 1951\u20131960. https:\/\/doi.org\/10.1038\/s41417-022-00510-0 (2022).","journal-title":"Cancer Gene Ther."},{"key":"58587_CR69","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.biopha.2018.06.040","volume":"106","author":"L Pan","year":"2018","unstructured":"Pan, L. et al. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6\/STAT3\/VEGFA pathway in hepatocellular carcinoma. Biomed. Pharmacother. 106, 68\u201376. https:\/\/doi.org\/10.1016\/j.biopha.2018.06.040 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"58587_CR70","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fgene.2022.959834","volume":"2022","author":"L Chen","year":"2022","unstructured":"Chen, L., Zhang, D., Zheng, S., Li, X. & Gao, P. Stemness analysis in hepatocellular carcinoma identifies an extracellular matrix gene\u2013related signature associated with prognosis and therapy response. Front. Genet. 2022, 13. https:\/\/doi.org\/10.3389\/fgene.2022.959834 (2022).","journal-title":"Front. Genet."},{"key":"58587_CR71","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.7150\/thno.35033","volume":"9","author":"Q Zou","year":"2019","unstructured":"Zou, Q. et al. Survey of the translation shifts in hepatocellular carcinoma with ribosome profiling. Theranostics 9, 4141\u20134155. https:\/\/doi.org\/10.7150\/thno.35033 (2019).","journal-title":"Theranostics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-58587-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-58587-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-58587-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T09:06:00Z","timestamp":1712567160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-58587-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,5]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["58587"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-58587-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,5]]},"assertion":[{"value":"26 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8013"}}